Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
This study is ongoing, but not recruiting participants.
Study NCT00738595. Last updated on January 12, 2009.
Information provided by Evotec Neurosciences GmbH
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smoking Cessation
Additional conditions recognized in this trial
Smoking
More general conditions related to this trial
Habits
Interventions listed in this trial
EVT 302
Placebo
Additional drug interventions recognized in this trial
Nicotine
Nicotine polacrilex
More general drug interventions related to this trial
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Evotec Neurosciences GmbH
PRA International
Clinpharm International Management Holding GmbH
Back to top of Main Content